TransCode Therapeutics
(NASDAQ) RNAZ
TransCode Therapeutics Financials at a Glance
Market Cap
$8.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$40.36M
EPS (TTM)
-$48.65
P/E Ratio
-0.18
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$8.69
Volume
1,441
Open
$9.46
Price
$8.69
Volume
1,441
Open
$9.46
Previous Close
$8.69
Daily Range
$8.69 - $10.75
52-Week Range
$3.82 - $20.99
Estimated Earnings Date
Aug 18, 2026
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$8.69
Volume
1,441
Open
$9.46
Previous Close
$8.69
Daily Range
$8.69 - $10.75
52-Week Range
$3.82 - $20.99
Estimated Earnings Date
Aug 18, 2026
RNAZ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TransCode Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Philippe P. Calais, PhD
Headquarters
Boston, MA 02109, US
RNAZ Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-99.39%
Return on Capital
-270.72%
Return on Assets
-25.68%
Earnings Yield
-5.56%
Dividend Yield
0.00%
Payout Ratio
-42.75%
Stock Overview
Market Cap
$8.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
950.30K
Volume
1.44K
Avg. Volume
58.90K
Financials (TTM)
Gross Profit
-$28.72K
Operating Income
-$32.14M
EBITDA
-$39.81M
Operating Cash Flow
-$4.99B
Capital Expenditure
-$6.66K
Free Cash Flow
-$4.99B
Cash & ST Invst.
$12.84M
Total Debt
$0.00
TransCode Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$23.94K
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$699.27K
N/A
Employees
12
N/A
Net Income
-$17.79M
-47.2%
EBITDA
-$17.53M
-45.7%
Quarterly Fundamentals
Total Cash
$12.84M
+10.9%
Total Debt
$0.00
N/A
Accounts Receivable
$2.30M
+612.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-25.68%
N/A
Return on Invested Capital
-21.17%
N/A
Free Cash Flow
-$4.98B
-160638.4%
Operating Cash Flow
-$4.98B
-160638.4%